The Effect of Esmadem Education Model on Spiritual Coping, Tolerance and Depression of High-Risk Pregnant Women
Launched by BURDUR MEHMET AKIF ERSOY UNIVERSITY · Jan 28, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a special education program called the Esmadem Education Model can help pregnant women cope spiritually, deal with their feelings about childbirth, and manage depression. The aim is to provide a more complete kind of care that not only focuses on the physical health of pregnant women but also supports their emotional and spiritual well-being. By participating, women may learn new ways to feel more connected to their pregnancy and reduce their fears about giving birth.
To be eligible for this study, women need to be between 18 and 35 years old, able to speak and understand Turkish, and currently in their 24th week of a healthy pregnancy. They should also be willing to attend educational meetings and not have any serious fears or mental health issues related to childbirth. Participants can expect to take part in a series of training sessions designed to support them through their pregnancy journey. It's important to note that women who miss three or more sessions or face certain health risks during the study will not be able to continue.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Able to speak, understand and write Turkish,
- • Ages 18-35,
- • Having a spontaneous pregnancy,
- • Volunteering to participate in the study,
- • According to the last menstrual period (LMS) or ultrasonography (USG) records, in the 24th week of pregnancy,
- • No risk factors,
- • Having a phone number to contact for educational meetings,
- • Participating in a pregnancy school
- Exclusion Criteria:
- • Pregnant women who had fear of childbirth
- • Chronic and/or psychiatric health problems
- • Failed to attend at least three sessions of the training program Who were at risk during any stage of the study Who could not be interviewed within the first 24 hours after birth were excluded from the study.
About Burdur Mehmet Akif Ersoy University
Burdur Mehmet Akif Ersoy University is a distinguished academic institution committed to advancing medical research and clinical trials. With a focus on innovative healthcare solutions, the university fosters a collaborative environment that integrates cutting-edge scientific inquiry with practical applications. Its dedicated research faculty and state-of-the-art facilities position the institution as a leading sponsor of clinical trials, aimed at enhancing patient outcomes and contributing to the broader medical community. Through rigorous ethical standards and a commitment to excellence, Burdur Mehmet Akif Ersoy University plays a pivotal role in the advancement of medical knowledge and the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported